1. Introduction {#sec1}
===============

Research using functional magnetic resonance imaging (fMRI) has made remarkable achievements that have shaped our current understanding of the neural mechanisms underlying emotional stress and their contributions to psychiatric disorders. While much has been accomplished within this field, there is still room for improvement, particularly in regard to clinical utility. Treatment providers and individual patients would benefit from clinically useful fMRI paradigms that help to provide information about how patients' current brain state is related to their symptoms and responses to stress, as well as to inform the treatment selection process. This information could be particularly useful as a psychoeducational tool to inform patients about how treatments target specific neural mechanisms. The goals of the current review are to discuss important methodological considerations for current human fMRI stress-related paradigms and to provide a roadmap for developing methodologically sound and clinically useful paradigms. While this review focuses primarily on the application of fMRI to studying the neurophysiology underlying emotional stress, many of the recommendations discussed in this review are applicable to other task-based neuroimaging modalities and other subfields of cognitive and clinical neuroscience.

There have been numerous studies using fMRI to examine the neurobiological underpinnings of emotional stress, and these studies have yielded a wealth of important information about the nature of emotional stress in healthy individuals and those with psychiatric disorders (for reviews see: [@bib39]; [@bib90]). While these studies have been useful in discovering neural markers of psychiatric disorders, the impact of this research on clinical practice has been astoundingly lacking ([@bib18]; [@bib67]). While dissemination of research into the clinical realm is an obstacle across mental health research ([@bib56]; [@bib88]; [@bib93]), it is often difficult to even imagine specific ways in which our current fMRI findings could be disseminated clinically at this point in time. This is despite the fact that the stress response is considered important in the development and maintenance of so many different mental health disorders ([@bib78]; [@bib115]). The lack of clinical utility may in part be due to the currently accepted methods for developing and testing fMRI tasks that turn a blind eye to potential future use in clinical settings with individual patients. In comparison to the methodical and step-wise process of developing a psychological assessment that is typical within the fields of neuropsychology or clinical self-report, a number of basic psychometric properties tend to be overlooked during fMRI task development. This includes considerations essential to reliability and validity ([@bib31]). At its most basic, the process of developing an assessment would include establishing reliability, meaning that the measure is stable and consistent, as well as validity, meaning that the assessment actually is measuring what it is designed to measure. In addition, the establishment of standardized normative data from a large sample of participants would support our understanding of how any one individual compares to the general population. While the cost of fMRI is one notable obstacle for its use as a method for clinical assessment, this is not insurmountable in all cases -- particularly given the widespread use of MRI scanners in hospital settings. Notably, other fields of medicine routinely utilize relatively expensive tests (e.g., anatomical MRIs, CT scans, EKGs, EEGs, etc.), reasoning that it is preventative of future medical problems and thus reduces future costs. In addition, developing fMRI paradigms that have known clinical utility would then allow for identification of cheaper methods for estimating neural stress response patterns (i.e., using EEG, physiological, or behavioral indices). Lastly, even if fMRI is only to be used as a tool for identifying biomarkers related to current and novel treatment targets in research (rather than clinical settings), psychometric issues remain a central obstacle.

There are several caveats and complexities to human neuroimaging research that have perhaps hindered the development of psychometrically-sound paradigms. Perhaps most notably, human clinical neuroscience remains an emerging field of study, and the process of establishing standards for the field is still underway. In addition to standardizing the process by which fMRI paradigms are developed, there is also a need for standardizing the preprocessing and analysis methods used when analyzing neuroimaging data acquired using fMRI. This is especially important since there have been a number of recent concerns about the reproducibility and generalizability of findings from neuroimaging studies ([@bib73]). Most human neuroimaging research to date takes an approach that is exploratory and requires a certain degree of fine-tuning depending on the population being studied and the paradigm being used. This malleable approach to data analysis, along with a certain lack of transparency in procedure, presents another potential roadblock to future clinical utility.

A clinically useful fMRI paradigm related to emotional stress would be one that would allow clinicians to better understand how a specific patient responds to and processes stress and in turn, make judgments about what treatments might be most appropriate and hopefully lead to better outcomes for that patient. In this review, we attempt to lay out a roadmap for developing fMRI assessments that elucidate the emotional stress response in ways that could be useful in a clinical setting. To facilitate the use of concrete examples demonstrating the use of such a 'clinical-utility roadmap,' we will focus specifically on posttraumatic stress disorder (PTSD) as a clinical group for whom the neurobiological stress response is highly relevant. We start with a review regarding the various types of fMRI paradigms used to identify neural substrates of emotional stress, including summaries of results concerning PTSD. We then summarize research with current stress-related fMRI paradigms in regards to reliability, validity, or the development of normative data. Finally, we outline a roadmap regarding optimal steps for supporting the further development of clinically useful emotional stress paradigms.

2. Paradigms used to assess neural responses to emotional stress {#sec2}
================================================================

A number of paradigms have been essential to our understanding of stress- and fear-related neurocircuitry and associated psychiatric disorders. These paradigms can be grouped into two domains, the *cognitive-behavioral* and *symptom provocation* paradigms ([@bib77]). Cognitive-behavioral paradigms utilize tasks designed to engage specific brain systems of interest, such as (1) passive viewing of facial stimuli, (2) passive viewing of emotionally valenced pictures, and (3) classical fear conditioning. Conversely, in symptom provocation paradigms, response to intentionally induced, disorder-relevant symptoms and control conditions are measured. Both sets of paradigms lend themselves to examinations across patient and healthy control populations, behavioral and pharmacological manipulations, as well as longitudinal and treatment studies. While there have been tasks developed to specifically probe various aspects of emotion regulation (i.e., cognitive reappraisal tasks; [@bib64]; [@bib76]), we restrict our following research summary to paradigms that have been more extensively utilized in research with PTSD, namely emotional face processing, emotional images/scenes, fear conditioning, and symptom provocation.

2.1. Emotional faces {#sec2.1}
--------------------

Paradigms employing facial stimuli usually have subjects passively view presentations of faces showing various types of emotions (e.g., fearful, sad, angry, disgusted, and happy), as well as neutral faces. Early studies compared responses between differently valenced facial stimuli, such as fearful vs. neutral or angry vs. happy faces ([@bib77]; [@bib20]). Another early study compared responses between matching similarly valenced facial stimuli and matching shapes ([@bib33]). Backward masking has also been used to assess face processing below conscious awareness (e.g., [@bib107]). Recent variations of emotional face paradigms require subjects to identify the gender of the presented face ([@bib8]), label the salient affect/emotion ([@bib26]), or match the face with available affective words ([@bib79]).

Studies show that passive viewing of human face stimuli robustly produces amygdala activation ([Fig. 1](#fig1){ref-type="fig"}; [@bib69]). While the amygdala is found to activate to facial stimuli regardless of valence ([@bib10]), there is some indication that it does so preferentially for fearful faces (e.g., [@bib108]; [@bib107]). It also appears that the amygdala is particularly sensitive to processing of facial emotional stimuli, as the amygdala has been found to activate more for emotional facial expression stimuli than emotional images ([@bib33]). Other regions activated by emotional faces include parahippocampal gyrus (PHG), posterior cingulate cortex (PCC), middle temporal gyrus, insula, ventromedial prefrontal cortex (vmPFC), dorsal anterior cingulate cortex (dACC), orbitofrontal cortex (OFC), visual cortex, putamen, and the cerebellum ([Fig. 1](#fig1){ref-type="fig"}; [@bib29]; [@bib75]).Fig. 1**Overview of Emotional Stress Paradigms**.A. Emotional provocation paradigms. Left --Examples of stimuli used in emotional faces ([@bib100]) and emotional scenes ([@bib47]) paradigms. Right -- Network of brain regions activated during the presentation of emotional stimuli (blue) and implicated in PTSD (red).B. Typical fear-associated learning paradigm. Left -- Examples of conditioned stimuli (CS) used in fear-associated learning paradigms. The CS+ (green triangle) is associated with an aversive shock (unconditioned stimulus; US) during fear acquisition (marked by electricity symbol), while the CS- (blue square) is not associated with the US. Right -- Network of brain regions activated during fear acquisition (blue), fear extinction (yellow), and implicated in PTSD (red).C. Symptom provocation paradigms. Left -- Examples of stimuli, both neutral and trauma-related, used in script-driven symptom provocation paradigms. Right -- Network of brain regions in which patients with PTSD exhibit significantly greater activation (red) than trauma-exposed controls (TEC) or where patients with PTSD exhibit significantly greater activation to trauma-related stimuli relative to neutral stimuli (yellow).Abbreviations: anterior cingulate cortex (ACC), dorsal ACC (dACC), rostral ACC (rACC), caudate nucleus (Caud), precuneus (Prc), retrosplenial cortex (RC), amygdala (AMY), parahippocampal gyrus (PHG), posterior cingulate cortex (PCC), prefrontal cortex (PFC), ventromedial PFC (vmPFC), orbitofrontal cortex (OFC), insula (INS), anterior insula (aINS), visual cortex (VC). hippocampus (HIPP), periaqueductal gray matter (PAG), dorsal striatum (DS). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

2.2. Emotional images and scenes {#sec2.2}
--------------------------------

The International Affective Picture System (IAPS; [@bib47]) has been used widely to study emotional processing. In a typical experiment, subjects passively view pleasantly and unpleasantly valenced pictures of varying arousal level expected to elicit corresponding emotions or stress responses ([Fig. 1](#fig1){ref-type="fig"}). Unpleasant, or aversive pictures for example include scenes of motor vehicle accidents, violence, or mutilated bodies, while pleasant pictures include images of families, animals, or neutral objects. When these paradigms are used with psychiatric populations, the content of the unpleasant or aversive pictures is not disorder-specific. Rather, these paradigms seek to probe emotional processing more generally (in contrast to symptom provocation paradigms, as described below). Researchers often examine both the anticipation of and responses to emotional images ([@bib61]; [@bib92]). Emotional pictures seem to activate a similar neural network as emotional face paradigms, including the amygdala, PHG, PCC, insula, vmPFC, dACC, OFC, and visual cortex ([Fig. 1](#fig1){ref-type="fig"}; [@bib69]; [@bib12]).

2.3. Fear conditioning {#sec2.3}
----------------------

Conditioning refers to the process of learning the association between two previously unrelated stimuli ([@bib68]). In a typical fear (Pavlovian) conditioning paradigm, a previously neutral conditioned stimulus (CS) is paired with an aversive fear-inducing unconditioned stimulus (US) ([@bib22]). After repeated presentations, the CS alone elicits a conditioned fear response (CR) that occurs independently of the US. Conversely, repeated presentations of the CS without the US gradually result in weakening of the CR, a process called extinction. While fear conditioning can examine how fear is learned, extinction focuses on how fear is extinguished, or rather how safety is learned and retained.

Although very similar to animal and non-imaging studies, human fear conditioning and extinction neuroimaging protocols have employed a tone, electric shock, thermal stimulus, air blast, odor, or an aversive image as US, and geometric visual figures, videos, light, tones, or faces as CS. Protocols vary on whether they employ trace (CS is presented some brief time before the US) or delayed conditioning (CS and US overlap, or the CS is immediately followed by the US), as well as on rate of reinforcement. While the US is typically brief in duration, the length of CS can range from brief to sustained, which is useful when fear vs. anxiety (i.e., anticipatory) responses are of interest ([@bib86]). In addition to the US-reinforced CS (CS+), human neuroimaging studies also typically employ a second, non-reinforced CS (CS-), which is not associated with the US ([Fig. 1](#fig1){ref-type="fig"}). This allows researchers to identify unique fear conditioned neural and psychophysiological responses to the CS+. Finally, protocols vary on retention (CRs in environment where extinction was learned), renewal (CRs in environment where fear was learned), and reinstatement (CRs to US after extinction is established) are tested ([@bib51]). Related paradigms also include observational fear conditioning paradigms (i.e., social learning of fear; [@bib65]; [@bib41]; [@bib32]) and instructed threat paradigms (where subjects are verbally instructed about the CS-US relationship; [@bib57]).

Several reviews and meta-analyses have summarized the neurocircuitry of fear conditioning and extinction ([@bib102]; [@bib28]; [@bib49]; [@bib39]; [@bib90]). In brief, this extensive body of research suggests that fear conditioning and extinction activate a functional network that includes amygdala, hippocampus, prefrontal cortex, anterior insula, dorsal striatum and midbrain structures ([Fig. 1](#fig1){ref-type="fig"}). During fear learning and expression, the amygdala is thought to play a crucial role in detection of salient stimuli and thus also in fear learning and expression, while the hippocampus is considered important for processing of information related to threat cues and contexts. Prefrontal regions, including dACC, dorsomedial prefrontal cortex (dmPFC), and vmPFC have been implicated in conscious threat appraisal, and particularly during anticipatory threat ([Fig. 1](#fig1){ref-type="fig"}). The anterior insula is believed to integrate cognitive, affective, and interoceptive states during conditioning to create a subjective representation of a fear experience. Fear expression (i.e., physiological autonomic arousal, defensive responses, avoidance behavior) is thought to be further modulated by the dorsal striatum, hypothalamus and the periaqueductal gray matter. In regard to extinction learning and recall, human neuroimaging studies have at least partially supported animal work by highlighting the importance of vmPFC-amygdala-hippocampus networks.

2.4. Symptom provocation {#sec2.4}
------------------------

Symptom provocation paradigms utilize disorder-related (e.g., trauma stimuli for PTSD \[[@bib36]\], phobic stimuli for specific phobia \[[@bib85]\], social evaluation for social anxiety \[[@bib9]\]) reminders such as pictures or script-driven imagery to uncover neuronal responses. Script-driven imagery procedures typically involve subjects composing several individualized scripts depicting personally experienced traumatic, neutral, and positive events, as well as various hypothetical events ([@bib48]; [@bib38]). While symptom provocation paradigms most often utilize visual stimuli, paradigms can also utilize other stimuli to provoke symptoms (e.g., anticipatory threat of aversive electrical stimulation to provoke anxiety symptoms \[[@bib87]\]). Findings from symptom provocation studies across anxiety- or trauma-related disorders often implicate common prefrontal-insula-amygdala networks ([@bib21]). Below, we have summarized neuroimaging findings relevant to PTSD specifically.

2.5. PTSD findings {#sec2.5}
------------------

The above described cognitive-behavioral paradigms have been used to assess differences between individuals with PTSD and healthy controls. A number of reviews and meta-analyses have summarized the neurocircuitry of PTSD ([Fig. 1](#fig1){ref-type="fig"}; [@bib21]; [@bib39]; [@bib90]; [@bib102]). Findings reflect relative functional alterations in PTSD patients in a number of brain regions involved in emotional processing and regulation, including the amygdala, hippocampus, insula, dACC, and vmPFC. Interpretations of these data often center on the idea that amygdala and insula regions are hyperresponsive in PTSD, while portions of the vmPFC may be hypoactive, failing to inhibit the amygdala. However, directionality of findings within these regions are often inconsistent, perhaps due to differences in experimental paradigms utilized or specific trauma populations included. Nevertheless, these alterations are thought to contribute to the exaggerated fear responses and persistence of traumatic memories, as well as deficits in extinction, emotion regulation, attention, and contextual processing observed in PTSD. Particularly clinically relevant for our understanding of PTSD are symptom provocation paradigms. A meta-analysis of 19 such studies showed that patients with PTSD exhibit significantly greater activation in retrosplenial cortex, precuneus, rostral ACC, and bilateral amygdala in response to trauma-relevant compared to neutral stimuli ([Fig. 1](#fig1){ref-type="fig"}; [@bib82]). These studies provide evidence for PTSD-related alterations in regions not only involved in salience-detection, but also self-referential and autobiographical processes.

As the literature delineating neural networks related to emotional stress in PTSD (and other psychiatric disorders) has been growing, there has been increasing attention towards how we might use such information to improve our clinical treatments ([@bib58]; [@bib67]). However, it is crucial to also recognize the methodological research that has been conducted on these stress-related fMRI paradigms, as it has important implications for how neuroimaging assessments may or may not be useful in the clinical realm.

3. Reliability of emotional stress paradigms {#sec3}
============================================

To improve the clinical utility of fMRI emotional stress paradigms, it is necessary to demonstrate their reliability. If the neural activity measured by an fMRI scan changes significantly based on when or where a scan is completed, clinicians cannot make meaningful recommendations to patients regarding their brain state and its relation to symptomatology. The primary forms of reliability are test-retest reliability, inter-rater reliability, and internal consistency. In the sections below, we will discuss each of these forms of reliability in the context of human neuroimaging and review previous fMRI reliability studies using emotional stress paradigms.

3.1. Test-retest reliability {#sec3.1}
----------------------------

Test-retest reliability refers to the stability of an assessment in its measurements across time. In regard to clinical utility, it is necessary to demonstrate that the measured brain activity is representative of more than just a single time point. For example, a patient with PTSD may show an altered amygdala response during a stress-related paradigm, but unless this alteration persists over time (at least without intervention or significant change in mental state), any relevant recommendations would be misguided. Test-retest reliability is also necessary for making meaningful conclusions in treatment studies. For example, a study might be examining whether a specific intervention may be useful for targeting specific patterns of the neurophysiological stress response. In order for the findings of this study to provide meaningful information about the impact of the intervention, it would have to first be established that a person who completes the same task at two different time points without any sort of intervention has a similar neurophysiological response profile. While treatment studies may include a control group to help account for such repeated measurements, this is not sufficient to account for potential errors in measurement. Rather, to support optimal clinical utility, it must be established that the response profile of an *individual person* is reliable across time.

To establish test-retest reliability, researchers typically conduct studies where participants complete the same fMRI protocol on different days and then examine how well neuronal activity correlates between the different scanning sessions. The intraclass correlation coefficient (ICC) provides a quantitative value of the consistency of multiple measurements ([@bib91]), and it is a commonly used statistical method utilized in test-retest reliability studies ([@bib7]; [@bib106]; [@bib113]) As compared to Pearson\'s *r* correlation coefficients, ICCS are better able to detect systematic error to determine absolute agreement between multiple measurements ([@bib106]). There are several different types of ICCs that can be calculated in test-retest reliability studies, and we will focus on the absolute ICC \[i.e., ICC(2, 1)\] and relative ICC \[i.e., ICC(3, 1)\]. The absolute ICC looks at the reliability of a measure by comparing exact agreement of data across subjects and sessions of a variable ([@bib91]). This means that a high absolute ICC indicates that a specific individual is likely to have a similar value at test and retest, regardless of the comparison group. Relative ICC looks at the consistent reliability using the means of a variable across sessions, meaning that the calculation of each individual\'s measurement is relative to the measurements obtained from others ([@bib89]; [@bib91]). Relative ICCs tend to have higher values than absolute ICCs since systematic changes in the mean are statistically controlled for, and thus, relative ICC is more comparable to Pearson\'s *r* than absolute ICC ([@bib89]). Each ICC is also calculated using either a "single-measure" or an "average-measure" approach ([@bib89]). Most studies utilize either relative or absolute "single-measure" ICCs, as these are meant to compare the agreement of independent measurements ([@bib89]). Average-measure ICCs, which could also be absolute or relative, consider the consistency across multiple measurements that will eventually be averaged together ([@bib89]) (for example, in the case of internal consistency or some cases of inter-rater reliability).

When reporting findings from previous test-retest studies of emotional faces tasks in fMRI, we indicate the type of ICC calculation that was used. The interpretation of ICC values typically follows the guidelines presented in [@bib25], which are that ICCs less than 0.4 are considered poor, ICCs between 0.40 and 0.59 are considered fair, ICCs between 0.60 and 0.74 are considered good, and ICCs greater than or equal to 0.75 are considered excellent. Note that there can be cases where ICCs are negative. ICCs are calculated using ratios of between-subject and within-subject variance, and negative ICCs occur when the within-subject variance exceeds the between-subject variance ([@bib46]). Negative ICCs should be interpreted as having a reliability of zero ([@bib4]).

An equally important methodological consideration for fMRI test-retest reliability studies is the process of determining which neurophysiological measurements are actually used to calculate ICCs. Most studies tend to use regions-of-interest (ROIs) that have previously been shown to be activated during a specific emotional stress paradigm. ROIs can be defined anatomically by using all of the voxels from within an entire region derived from a brain atlas, or ROIs can be defined functionally by using only the voxels that are significantly active during task performance. Once the ROIs are defined, mean contrast values across all voxels in each ROI from an individual are averaged and then are used to calculate ICCs. Other approaches use procedures for selecting individual voxels (i.e., using the peak activation voxel within a region) to calculate ICCs. The implications of these and other methodological variations will be discussed in regard to the findings from individual studies. Below, we review the available studies for each type of stress-relevant task reviewed in the previous sections, namely *cognitive-behavioral* (includes emotional faces, emotional images/scenes, and fear conditioning) and *symptom provocation* tasks.

### 3.1.1. Emotional faces {#sec3.1.1}

There have been several test-retest reliability studies using facial stimuli paradigms ([@bib43]; [@bib84]; [@bib55]; [@bib70], [@bib71]; [@bib83]; [@bib101]; [@bib50]; [@bib62]), the results of which are summarized in [Table 1](#tbl1){ref-type="table"} (including information about tasks, test-retest intervals, contrasts, ROIs, and type and value of ICCs). These studies have primarily focused on the amygdala, though as shown in [Table 1](#tbl1){ref-type="table"}, other regions have also been reported. The ICCs reported have varied widely, even within the amygdala. This is likely due to different methods used in regard to the specific contrast or how regions of interest are defined. Specifically, ICCs tended to be greater when contrasting face trials (regardless of valence) to either shape trials or fixation as compared to ICCs when contrasting between specific face valences (e.g., fearful versus happy; [@bib43]; [@bib83]; [@bib50]). In regard to regions of interest, analyses utilizing functionally-defined ROIs ([@bib43]; [@bib84]; [@bib55]; [@bib83]; [@bib101]) typically led to higher ICCs than analyses utilizing anatomically-defined ROIs ([@bib43]; [@bib83]; [@bib101]; [@bib50]). However, studies using peak voxels showed similar reliability to anatomically-defined ROIs using the same data ([@bib70]; [@bib62]).Table 1Test-retest reliability results from studies using emotional faces tasks.Table 1Author, YearNTest-retest IntervalTaskContrastMethodROIICCs[@bib43]150, 2, 8 weeksViewingFaces--FixationAnatomical ROIsL Amygdala.28(3 scans)(Fearful)R Amygdala.18Functional ROIsL Amygdala.**67**R Amygdala.**44**[@bib84]12Range: 1--8 weeksViewingFaces-BaselineFunctional ROIsL Amygdala.**83**(Fearful)R Amygdala.**69**[@bib55]13Median: 21 monthsMatchingFaces--ShapesFunctional ROIsL Amygdala-.08Range: 13--22 months(Fearful/Angry)R Amygdala.**59**[@bib70]25Mean: 14.6 daysMatchingFaces--ShapesAnatomical ROIsL Amygdala.16Range: 12--21 days(Fearful/Angry)R Amygdala--.02Peak VoxelsL Amygdala.18R Amygdala.07[@bib71]25Mean: 14.6 daysMatchingFmL: HabituationAnatomical ROIsL Amygdala.**41**Range: 12--21 days(Fearful/Angry)R Amygdala.**48**Regression: HabituationAnatomical ROIsL Amygdala.25(Fearful/Angry)R Amygdala.**53**[@bib83]27Mean: 88.9 daysMatchingFaces--ShapesAnatomical ROIsL Amygdala.**42**(Fearful)R Amygdala.36Functional ROIsL Amygdala.32R Amygdala.**40**L FFA.**50**R FFA.**50**[@bib101]180, 3, 6 monthsLabelingFaces-FixationAnatomical ROIsL Amygdala.28\*(3 scans)(Fearful/Happy/R Amygdala.34\*Neutral)Functional ROIsL Amygdala.10\*R Amygdala.35\*[@bib50]15Mean: 23 daysClassifyingFaces--FixationAnatomical ROIsL Amygdala.29\*Range: 15--34 daysGender(Fearful)R Amygdala.19\*L FFA-.24\*R FFA-.10\*[@bib62]29Mean: 14.3 daysMatchingFaces--ShapesAnatomical ROIsL Amygdala.**43\***(3 scans)(Fearful/Angry)R Amygdala-.14\*sgACC.33\*Peak VoxelsL Amygdala.30\*R Amygdala-.50\*sgACC-.13\*R FFA.**83\***[^1]

Of particular interest, three test-retest studies used the same dataset but analyzed the data in different ways ([@bib1a]; [@bib70], [@bib71]). The 2012 study found poor reliability for mean activation in the amygdala both when using anatomically-defined ROIs and peak voxels (all ICCs \< 0.18; [Table 1](#tbl1){ref-type="table"}). Rather than calculating reliability for mean activation in the amygdala, the [@bib71], study instead calculated reliability of amygdala habituation during task performance. The habituation of the amygdala in response to threatening faces has been noted in the literature for some time ([@bib10]; [@bib112]; [@bib24]), but this was the first paper to directly examine how this relates to reliability. Amygdala habituation was calculated using two different methods: (1) the amplitude difference between the first and last of the four presentation blocks and (2) modeling of habituation using a regression approach that estimated the rate of habituation ([@bib71]). They found improved ICCs for both the left and right amygdala using both habituation calculations (most ICCs in the 0.40 - 0.50 range; [Table 1](#tbl1){ref-type="table"}). The findings from this study demonstrated that amygdala habituation was more reliable across time than mean activation amplitude. [@bib1a] also calculated reliability using an non-traditional methodology. In this case, they used principles of graph theory, which consider the way that activity from multiple regions correlate when simultaneously active ([@bib1a]). Compared to their original study, the ICCs were improved when using global connectivity (ranging from 0.51 to 0.68). The findings from these two studies are important in that they demonstrate how reliability may be improved when using alternative methodologies for analysis. However, it is also important to consider how the measures extracted using these methodologies are different from previous studies comparing healthy and clinical populations. Thus, the clinical relevance of these methods would also have to be determined (see validity section below).

### 3.1.2. Emotional images and scenes {#sec3.1.2}

There has only been a single fMRI test-retest reliability study using an emotional images/scenes task. [@bib95] conducted a test-retest reliability study in which twenty-four volunteers viewed emotional scenes in a block design during two sessions, one week apart. They examined the BOLD response to either fear-inducing or disgust-inducing IAPS images contrasted against neutral IAPS images. Cohen\'s Kappa, which is a reliability metric that is different from the ICC but similarly ranges from 0 to 1, was used to calculate the reliability of significant activations across the whole brain. The statistically active regions included the amygdala, vmPFC, OFC, PCC, and hippocampus. Cohen\'s Kappas showed low reliability of the activations between the two scans with the median value falling below 0.1. While these results were not encouraging regarding the reliability of activation to emotional images/scenes, it could be useful for future research to examine whether reliability may be improved by utilizing an ROI-based approach or other alternative methodologies.

### 3.1.3. Fear conditioning and extinction {#sec3.1.3}

Thus far, there has not been a single fMRI fear conditioning/extinction study published that focuses on test-retest reliability, though there have been several behavioral test-retest reliability studies ([@bib27]; [@bib114]; [@bib99]). All of these studies used skin conductance responses (SCRs) to quantify the fear response, while [@bib99] also included a measure of startle response. Each study had two testing sessions on different days, utilizing two versions of the task (each with different stimuli) to avoid habituation between sessions. Findings from two of these studies reported SCRs to have fair to good reliability and that reliability was generally better during the fear conditioning phase than the fear extinction phase ([@bib27]; [@bib114]). In the third study, both SCRs and the startle response showed poor reliability, but the reliability findings were also generally better during the fear conditioning than the fear extinction phase ([@bib99]). The findings from these studies have provided valuable information regarding the reliability of the physiological components of fear conditioning and extinction tasks. However, it is important for future work to test the reliability of neural activations during the various phases of fear learning.

### 3.1.4. Symptom provocation {#sec3.1.4}

There has only been a single fMRI test-retest reliability study using a symptom provocation paradigm. [@bib87] conducted a test-retest reliability study in which fourteen volunteers completed a paradigm involving anticipation of aversive transcutaneous electric nerve stimulation during two sessions, 10 days apart. They used fMRI to examine the neural response to periods of anticipatory threat (cues associated with 50% likelihood of shock) contrasted against periods of rest (no likelihood of shock). Absolute ICCs were computed using functionally-defined ROIs, defined by centering 8-mm spheres on the local maxima of regions that were significantly active at both time points. This approach may in theory lead to higher ICCs, as it focuses analyses to voxels known to be active at both test and retest. However, whether such an approach is more or less generalizable to other groups or individuals is unknown. In this study, ICCs showed good reliability in the left inferior parietal lobe (ICC = 0.66), fair reliability in the right inferior frontal gyrus/anterior insula (ICC = 0.54), and poor reliability in the left inferior frontal gyrus/anterior insula (ICC = 0.33), cingulate/medial frontal gyrus (ICC = 0.25), and right inferior parietal lobe (ICC = −0.06). While these findings were somewhat encouraging, additional research is needed to determine the most reliable regions of interest and contrasts to use in analyses with the various symptom provocation paradigms.

3.2. Inter-rater/multi-site reliability {#sec3.2}
---------------------------------------

Inter-rater reliability refers to stability of an assessment in its measurements across different raters/assessors ([@bib31]). In the context of fMRI, reliability across different neuroimaging research sites (i.e., multi-site reliability), using different scanners, could be considered a form of inter-rater reliability. Multi-site reliability is crucial to supporting the future clinical utility of fMRI. Regardless of the neuroimaging center or treatment at which a patient is being assessed, the results need to be consistent in order to make meaningful interpretations and recommendations. There have only been two multi-site reliability studies using fMRI emotional stress paradigms ([@bib13]; [@bib30]), but these studies have provided invaluable information regarding consistency of findings and provide model frameworks for future multi-site reliability studies.

In a study conducted by [@bib13], eighteen participants completed the same emotional working memory task across four different MRI sites. ICCs were calculated for activation of every voxel of the brain to emotional versus neutral distractors during visual working memory maintenance. Generally speaking, the authors reported that a greater proportion of variance was attributable to the "person" factor than the "site" factor. They also found that as more data from multiple runs (i.e., greater than four runs) was averaged together, ICCs across most regions of the brain fell within the fair to good range ([@bib13]). The findings support both multi-site and test-retest reliability and provide evidence that using more data (i.e., more trials in a task) can improve reliability across place and time. In a study by [@bib30], eight participants completed an emotional faces task twice on successive days at eight different MRI sites ([@bib33]; [@bib2a]). Similar to the [@bib13] study, they found that a greater proportion of variance was attributable to the person variance than site variance ([@bib30]). Instead of ICCs, they calculated the generalizability coefficient or the 'G-coefficient', which ranges from 0 to 1 and calculates test-retest reliability using the relative difference in means similar to the relative ICC ([@bib11]; [@bib89]; [@bib105]). Of interest to this review, the authors calculated reliability for both mean activation and habituation of the amygdala. Similar to the findings mentioned above ([@bib71]), G-coefficients were somewhat greater for amygdala habituation (mean: 0.32; range: 0.00--0.71) than mean activation (mean: 0.22; range: 0.00--0.44). The G-coefficients reported in the original publication were relatively high compared to previous publications. However, as noted in a recently published clarification on the study, these G-coefficients were somewhat misleading in that they were a product of all sixteen sessions in aggregate ([@bib17]). The ICC values provided in the clarification were mostly in the poor range. Regardless of test-retest reliability, the findings from these two studies both showed that more variance was attributable to person than to site, which is encouraging for multisite-reliability ([@bib13]; [@bib30]).

3.3. Internal consistency {#sec3.3}
-------------------------

Internal consistency is the reliability of responses to individual items throughout an assessment ([@bib31]). For fMRI, it would be important to demonstrate that the various stimuli used consistently and reliably invoke the expected behavioral response in individuals (e.g., self-reported ratings of valence and arousal) as well as the expected neural response. While this is rarely done when developing fMRI-related tasks, it could maximize the robustness (and eventual reliability) of the task as a whole.

There has not been much work assessing the internal consistency of emotional stress paradigms. However, a recent study used an emotional faces paradigm and assessed the internal consistency of neural responses in a large sample (*N* = 139) of adolescents ([@bib42]). The results demonstrated excellent internal consistency for amygdala activation when looking at face and shape contrasts separately, but the internal consistency estimates were poor for faces-shapes contrasts ([@bib42]). The generalizability of these findings outside of an adolescent sample is unclear and thus requires further study.

3.4. Reliability summary {#sec3.4}
------------------------

With the exception of emotional face paradigms, there is a dearth of research assessing reliability of stress-related neuroimaging paradigms. Overall, findings from even the emotional face paradigms have been highly variable, ranging from excellent ([@bib43]; [@bib84]; [@bib55]; [@bib83]; [@bib30]) to poor test-retest reliability of neural activations ([@bib101]; [@bib50]; [@bib62]). This high variability in fMRI reliability findings is not limited to emotional paradigms. A review by [@bib7] examined test-retest reliability findings across a broader range of fMRI paradigms. Across 15 studies, they found that the mean ICC value was 0.50 and that mean ICCs for each individual study ranged from poor (0.33) to good (0.66). As made apparent across studies using emotional face paradigms, specific regions of interest and/or specific contrasts may prove to be more reliable than others. Future research should continue to assess the reliability of existing emotional stress paradigms (and identify the most reliable variables), make attempts to improve the reliability of these paradigms, and seek to establish reliability of novel paradigms.

In regard to improving the reliability of existing paradigms, there are some additional considerations unique to fMRI research regarding data preprocessing and analysis methods. These considerations would include decisions about voxel-wise thresholding, cluster correction, and correction for motion or physiological noise. Establishing consistency in these methods across studies or demonstrating that findings are robust to variations in these methods would be beneficial. Other information that might be beneficial would include the time of recording, current level of sleepiness, and any other information that could potentially affect the data. As a standard practice, researchers should provide as much detail as reasonably possible when describing their analysis methods. This will not only allow for other researchers to adequately reproduce their study protocols but can also help to elucidate environmental variables that could be controlled in order to optimize reliability.

Finally, it is important to note that producing more reliable fMRI task paradigms/methods will be beneficial to the field of psychiatric neuroimaging as a whole. Assessments with higher reliability have increased power to detect true effects and also require lower sample sizes to do so ([@bib16]). There have been important concerns recently raised about the replicability and robustness of fMRI findings ([@bib73]). In addition to increasing sample size and conducting replication studies, improvement of reliability could be an important step in addressing these concerns ([@bib98]; [@bib16]).

4. Validity of stress paradigms {#sec4}
===============================

Measuring changes in brain activity during the performance of mental tasks can offer a fascinating window into the mechanics of the human mind. However, these measured changes in activity cannot be considered clinically useful until they are shown to have meaningful relationships to observable, disorder-relevant behavior and related theoretical constructs. Demonstrating the validity of an assessment provides support that an assessment is actually measuring what it is designed to measure. There are several forms of validity to examine when developing psychological assessments. We propose that while neuroimaging research has addressed validity much more consistently than reliability, the field would still benefit from further efforts aimed at establishing certain aspects of validity. In the section below, we briefly define and summarize different forms of validity, review relevant research, and discuss how these different forms of validity can be established in the context of neuroimaging research.

4.1. Face, content, and construct validity {#sec4.1}
------------------------------------------

When developing an emotional stress paradigm, it is important to first address face, content, and construct validity. Face validity and content validity are related in that they both look at how well a measure appears to measure what it is supposed to, but they differ based on who makes those judgments ([@bib31]). While face validity focuses on the perspective of the person completing the measure, content validity is concerned with expert opinions of the measure ([@bib31]). To a certain extent, face and content validity are both subjective in nature, but they are still an important starting point for developing a task. For example, a task purporting to measure emotional response to images/scenes could use images that are judged at face value to be emotionally relevant by participants (face validity) and experts (content validity). Construct validity is a more objective measure of validity that looks at how well a measure tests the psychological or theoretical construct it is supposed to measure ([@bib31]). To test construct validity, researchers can calculate correlations with measures of the same or similar constructs (e.g., for two different measures related to stress) or with different levels of responses (e.g., self-report to behavioral or physiological responses). For example, an fMRI paradigm that focuses on eliciting fearful emotions could demonstrate that participants report fear while performing the task, that individuals rating high levels of fear on this task also report high levels of fear on other behavioral or self-report tasks, and that these ratings also show a relationship with physiological responsivity (i.e., heart rate, galvanic skin response). The field has a history of identifying how activation relates to self-reported symptoms, and this is particularly true for fMRI studies of PTSD ([@bib21]; [@bib39]). However, relationships between neural activation and physiological responsivity or behavior outside of the scanner have been less of a focus. Regardless of whether an emotional stress paradigm falls within the cognitive-behavioral or symptom provocation domain ([@bib77]), it is necessary to demonstrate that these tasks are testing the psychological constructs that they are attempting to test. Note that such analyses should be conducted to confirm a priori hypotheses concerning relationships. While exploratory analyses regarding the relationship between neural activations and behavioral or clinical constructs can be useful in generating hypotheses, such relationships should be confirmed in replications. One last consideration is how factors related to validity may interact with those related to reliability. For example, using stimuli of specific relevance to a population (e.g., as in symptom provocation paradigms) or individual (e.g., personalized trauma scripts) may have a high level of validity, but may be related to lower test-retest reliability as compared to more standardized sets of stimuli (e.g., standardized emotional stimuli).

4.2. Criterion validity {#sec4.2}
-----------------------

Criterion validity is how well the results from a test relate to external measures or outcomes and includes both concurrent and predictive validity ([@bib31]). Concurrent validity is the degree to which a test relates to existing measures or "gold standards", which in psychiatry can often be considered diagnoses or clinical symptoms. Predictive validity is the degree to which a test accurately predicts outcomes that will take place in the future ([@bib31]). Predictive validity is particularly relevant to the future clinical utility of emotional stress paradigms. For example, does activation during a task predict outcomes, either naturalistically or to treatment? This is very important for utility as it would shape treatment recommendations made by a clinician. An additional form of validity related to criterion validity is incremental validity, which is the ability of a measure to provide accurate results that are better than existing measures ([@bib31]). To establish the incremental validity of emotional stress paradigms, it would require a demonstration that these measures provide predictive or explanatory value that is better than existing measures. There have been a few studies investigating predictors of treatment response for PTSD, using emotional faces ([@bib14]; [@bib26]), anticipation of emotional images ([@bib103]; [@bib1]), as well as emotional conflict and regulation tasks ([@bib26]). Across these studies, activation within areas of the ACC/dmPFC, dorsolateral PFC, and amygdala have been highlighted as predicting response to cognitive-behavioral treatments for PTSD. However, the specific task utilized was different in all studies, the directionality of findings was variable, and the sample sizes and analytic techniques used do not yet allow for using such data to make individual-level predictions.

To progress towards clinical utility, neuroimaging research can also be aimed at identifying (a) whether paradigms developed to target a specific therapy-related process (i.e., cognitive reappraisal, fear extinction) are sensitive to those treatment effects and (b) identify novel treatment strategies to most effectively target identified neural dysfunctions. A few studies have used fMRI to investigate changes in neural response with cognitive-behavioral treatments for PTSD, utilizing emotional faces ([@bib23]), affective Stroop ([@bib81]; [@bib96]), anticipation of emotional images ([@bib1]), and fear conditioning, extinction and recall ([@bib35]) tasks. These studies have highlighted decreases in amygdala or insula activation as well as variable directionality of changes in rostral or dorsal ACC activation. Changes in subgenual ACC and parahippocampal gyrus were also implicated in the fear learning study, with decreased activation in these regions and increased functional coherence between PFC regions (rACC, vmPFC, sgACC) being reported during extinction recall ([@bib35]). While these studies have been conducted with varying tasks and analytic methods, it is reassuring that there is some consistency in the regions identified. However, many of these studies were conducted with relatively small samples or did not include a treatment comparison group to control for repeat testing. As we have discussed, the reliability of the tasks used is either unknown or less than sufficient and thus, may limit the generalizability of these findings. Regardless, these initial studies suggest that cognitive-behavioral and/or trauma-focused interventions may target prefrontal-insula-amygdala circuitry, offering a potential framework and hypotheses for future work.

5. Development of normative data {#sec5}
================================

When a self-report or neuropsychological assessment is used clinically, the practitioner usually uses some sort of metric that compares their patient to a normative population. For example, with PTSD measures, the practitioner is likely to use normatively defined cutoffs to establish whether the person screens positive for potential PTSD diagnosis or whether they score in the mild, moderate, or severe range ([@bib104]). Neuropsychologists often establish a *z* or *t* score to represent how any one patient performed relative to a normative population ([@bib60]). Such a comparison provides the clinician and patient with important information on (a) whether deficits being described are more than expected given this person\'s demographic, and (b) the severity of these deficits. Furthermore, neuropsychological assessments often provide individuals with information on both absolute and relative strengths and weaknesses, as well as what the performance may mean in terms of daily functioning, diagnosis, treatment options, and prognosis. Similarly, clinical symptom measures are often used by clinicians to identify the targets of therapy (e.g., in identifying whether a patient\'s symptoms are more associated with depression versus PTSD and designing treatment accordingly).

If one is to use fMRI stress-related assessments clinically, it is difficult to imagine this being possible without normative data to which to compare individual responses. Issues with reliability or validity, as discussed in the above sections, can prevent such normative data from being meaningful. Thus, the establishment of normative data would have to come after consistent, reliable, and valid methodology has been identified (e.g., in terms of specific paradigms, contrasts analyzed, preprocessing methods, regions of interest, etc.). The establishment of normative data requires researchers to establish the distribution of responses in the general population, replicate that across samples, as well as perhaps sub-samples based on gender, age, ethnicity, and other relevant factors (e.g., socioeconomic factors; [@bib63]). Such studies obviously require very large samples. Notably, there are completed or currently ongoing studies with data-sharing initiatives, which have resulted in large repositories of fMRI data (e.g., OpenfMRI, [@bib72], [@bib74]; international Study to Predict Optimized Treatment for Depression, iSPOT-D, <http://www.brainresource.com/home.html>, [@bib109]; the NIH Adolescent Brain Cognitive Development (ABCD) Study, <https://abcdstudy.org/about.html>). Thus, what may have seemed impossible in the past regarding the collection of large, normative samples is now a practical reality within fMRI research. Interestingly, we are aware of only one study that was published with the explicit purpose of providing normative data in relation to functional MRI ([@bib2]). The authors provide normative data for default mode network connectivity during resting state, based on the iSPOT-D study. This study, although not focused on stress-related tasks, provides a useful framework for how functional MRI research of stress responses may progress in a way that lends itself to clinical utility.

6. Roadmap for the optimal development of an fMRI paradigm {#sec6}
==========================================================

From the above review of the literature, it is obvious that there are several gaps within the field of stress-related human neuroimaging that limit its clinical utility. However, given the complications of functional neuroimaging, it can be difficult to imagine how we might fill these gaps to move forward. Here, we aspire to sketch a basic roadmap for the optimal development of emotional stress fMRI paradigms, recognizing primary obstacles for each step (see [Fig. 2](#fig2){ref-type="fig"}).Fig. 2**Clinical Utility Roadmap for fMRI Emotional Stress Paradigms**.This diagram outlines a "roadmap" for researchers to use as a guide for designing methodologically sound emotional stress paradigms for fMRI studies. Note that between these steps are bidirectional arrows, recognizing the possibility and likelihood that these steps may not be completed in a linear fashion and that steps may need to be repeated during the development process.Fig. 2

6.1. Face/content validity and internal consistency {#sec6.1}
---------------------------------------------------

We propose that the initial step in the development of stress-related neuroimaging paradigms is to consider *face and content validity*. This would involve obtaining input from experts in the field, as well as populations of interest (e.g., PTSD patients) during the development process ([@bib80]). Depending on the purpose of the task, one would likely incorporate clinical understanding of specific symptoms or treatment-related constructs (i.e., such as was done with emotional reappraisal tasks; [@bib15]). Furthermore, one may also consider translating tasks utilized in human behavioral or animal stress-related research for use in conjunction with human neuroimaging, as has been done with fear conditioning/extinction paradigms ([@bib37]) and recently developed approach-avoidance conflict paradigms ([@bib44]). Assessment regarding *internal consistency* of a task may begin with a focus on behavioral or self-report aspects of the task, ensuring that the stimuli used consistently and reliably invoke the expected response in individuals (e.g., in terms of self-reported ratings of valence, arousal, etc.). Trials that do not invoke the expected responses would be replaced or altogether dropped from the task. This would help to ensure that the individual trials or stimuli used in the task are consistent and robust prior to initial testing in more costly neuroimaging studies. Notably, it would then also be optimal during initial neuroimaging studies to assess for whether individual trials are consistent in their ability to invoke the expected neural response. While this is rarely done when developing fMRI-related tasks (but has been used to assess event related potentials \[[@bib66]\]), it could maximize the robustness (and eventual reliability) of the task as a whole. In this vein, item response theory could allow for estimating neural responses using models that incorporate individual trial discrimination parameters ([@bib97]). Inter-"item" correlations, and random sampling methods (i.e., for assessing Cronbach\'s Alpha) would optimally be utilized to confirm the consistency of response patterns across trials. This phase of development would be the optimal time to also develop different versions of the task if applicable, so that one could assess for consistency across trials and versions. Development of different versions of the task would lend itself well for assessment of treatment effects. Note that while the reliabilities of behavioral and neural responses are examined separately, the relationship between these responses can be explored when assessing construct validity. While one may assume that greater reliability of a behavioral response will in turn lead to greater reliability in a neural response, this may not necessarily be the case and should be explored in future studies.

6.2. Construct validity in healthy controls {#sec6.2}
-------------------------------------------

As is usually the case in fMRI studies, the initial validation of a task in conjunction with neuroimaging would likely begin using healthy control populations. Such studies would not only allow for investigation of internal consistency as discussed above, but also for initial construct validation. Depending on the purpose of the task, this would either include (a) identifying that the task is associated with activation in the expected brain regions (as established, for example, by other cognitive-behavioral types of paradigms that aim to probe the similar neural systems), or (b) that task-related neural activations are associated with specific behaviors or self-report ratings relevant to the construct of interest. Although healthy control studies usually do not support investigating relationships with relevant clinical symptoms, construct validity can be assessed by examining relationships with relevant dimensional, potentially transdiagnostic psychological traits, behavioral or physiological indices collected during the fMRI paradigm, and/or other related paradigms conducted outside of the scanner. For example, as evidence of construct validity, one could view reports that vmPFC activity during fear extinction related to an extinction retention index based on SCRs ([@bib59]). We propose that it may be *optimal* for tasks to have concurrent behavioral or physiological indices, which would not only be used for validation, but would also continue to be used alongside the task during further development. This would increase the likelihood of identifying cheaper analogues to neural activation patterns, which can subsequently be disseminated more easily than fMRI to clinical contexts. Furthermore, this information would be crucial during the construct validation stage to make any necessary task modifications. Thus, if the task is not serving its initial purpose of probing specific circuits, or tapping into a specific construct, the task could be modified to do so more effectively.

6.3. Test-retest reliability {#sec6.3}
----------------------------

After developing tasks that have face validity, internal consistency, and initial construct validity in healthy control samples, the next optimal step would be to conduct studies to examine the test-retest and perhaps even multi-site reliability of the task. This step is time and resource intensive and is therefore often ignored within fMRI research. However, if a task does not consistently produce similar patterns of neural activation, clinical interpretations on an individual-level cannot be made. In addition, reliable tasks are likely to be more robust when used in the context of prediction or treatment response ([@bib45]). As discussed in this review, there have been several test-retest fMRI studies (and a few multi-site reliability studies) focused on emotional face tasks. However, there has been a surprising lack of such studies with other stress- or emotion-related tasks. Even with emotional faces tasks, the ICCs reported by test-retest reliability measures were highly variable (see [Table 1](#tbl1){ref-type="table"}). We propose that such reliability studies, rather than simply aiming to test whether or not the *commonly* used metrics of the task are reliable, focus on identifying the specific metrics that do in fact demonstrate adequate reliability. FMRI response is not a singular measure, but rather a conglomerate of measures from various groupings of voxels or regions of interest. Moreover, most tasks examine a range of potential contrasts of interest. Therefore, it is quite possible to identify the specific indices that evidence most reliability, as has been done with functionally-defined amygdala habituation to faces-shapes contrast for emotional faces tasks by [@bib71] and with graph theory by [@bib1a]. The use of factor analytic or other data reduction techniques (e.g., independent component analysis; [@bib19]) could be used to identify latent factors or components representing brain responses to emotional stress tasks (as has been done with resting state in conjunction with intervention research; [@bib94]). Such factors may be more stable than individual measures, as a change between testing sessions in a few voxels or even one brain region is going to have a limited impact on the overall factor. Computational approaches (such as Bayesian approaches) have the potential for modeling complex behavioral and neural responses in ways that further elucidates our understanding of psychiatric symptomatology ([@bib40]), and which may also prove to be more stable over time than traditional measures.

It would be further optimal to conduct multiple test-retest studies, with different time frames in between (i.e., a few days, a few weeks, a few months). However, if the task is going to be used to assess for treatment effects or to determine whether a treatment targets a specific neural network, test-retest studies should be designed to match the typical length of treatment. Another issue with test-retest reliability is whether there are environmental variables that need to be controlled for in order to increase reliability. In the cardiovascular field for example, it is often specified what environmental variables should be controlled for (e.g., caffeine/tobacco/food intake, menstrual phase, room temperature, etc.; [@bib34]). In fMRI research related to stress, the control of these types of variables, as well as data processing steps, may help to increase test-retest reliability. However, practical considerations for implementing environmental control should not be ignored (ease of scheduling; burden on participants). It is ultimately important to establish measures that are reliable in the settings in which they would be administered.

6.4. Normative data {#sec6.4}
-------------------

Once a task is developed and specific indices have been identified that demonstrate evidence of construct validity and adequate test-retest reliability, the collection of normative data would be an important next step. As mentioned previously, fMRI researchers have not previously focused on the publication of normative data. While we suggest this as a step that would optimally be conducted prior to research with clinical populations, we recognize this is often not going to be the case. Normative data requires large samples sizes and researchers likely will hesitate to invest resources towards this until they have established that the task indices are clinically meaningful. Regardless of when such normative data is established, it is a necessary and powerful step towards using the indices to make meaningful interpretations at the individual level.

6.5. Criterion validity {#sec6.5}
-----------------------

The last step in development of clinically useful stress-related neuroimaging paradigms would be to establish criterion validity in patient samples. Cross-sectional research has offered insights into potential neural systems relating to psychiatric symptomatology and are important steps in establishing concurrent validity of the task indices. However, it is difficult with cross-sectional research to establish predictive validity, that is, whether findings represent deficits or compensatory responses that are adaptive for long-term functioning. These studies also cannot determine whether or not commonly used treatment modalities already target the identified neural dysfunctions effectively. Thus, longitudinal research addressing predictive validity is perhaps one of the most important steps in moving the neuroimaging field toward meaningful clinical utility. As noted above, there have been a few studies conducted to identify neural predictors and changes related to cognitive-behavioral therapy for PTSD. However, due to small sample sizes, limits in statistical approaches, and inconsistencies in findings across studies, there remains a lack of obvious translation of findings to individual patients in the clinical realm. In predictive research, the use of machine learning techniques with separate participant samples for training and replication of the predictive model will represent substantial progress in this regard ([@bib3]; [@bib54]). Note that while these predictive models are providing evidence of predictive validity, this replication across samples could also be considered a form of reliability. However, eventually, prospective research will likely be needed to examine the effectiveness of such a predictive test for enhancing outcomes via treatment selection ([@bib53]). It is also important for researchers to establish the accuracy and specificity for any given predictor and establish that it is more meaningful than simply measuring symptom severity or diagnosis, which would provide evidence of incremental validity. This too, is a step in which identification of behavioral, physiological, or self-report variables that can be used to estimate the neural response profiles would be beneficial for making such findings practical and able to be disseminated in the clinical setting.

Given the infinite number of different treatment modalities, the goal of identifying neural predictors of treatment response or targets of various treatment strategies can seem overwhelming. However, it is important to recognize that we are currently in a place where clinicians have very little information on which to guide their treatment decisions. Thus, identifying a measure that can robustly and reliably predict how well an individual person would likely respond to even just one specific intervention (e.g., cognitive restructuring techniques), would in and of itself be useful. Identifying a brief intervention that is known to target specific neural dysfunctions when observed in a patient (e.g., to enhance recruitment of dorsolateral PFC regions during emotion regulation), would offer a meaningful place for clinicians to start.

6.6. Roadmap summary {#sec6.6}
--------------------

None of the paradigms used in stress-related research have been developed in such a sequential and thorough way. Emotional faces tasks have undergone the most scrutiny and are the most widely used in reliability studies, yet the measures often relied upon in the majority of studies are not necessarily the measures found to be most reliable ([@bib1a]; [@bib70], [@bib71]). Measurements focusing on habituation or graph theory have been mentioned preciously, but other potential methods that should be explored as potentially more stable measurements include multivariate pattern analysis, which examines how patterns of voxels directly relate to the psychological construct of interest (e.g., pain intensity; [@bib110]), or machine-learning measures including support vector machine (SVM) datasets that can be transferred across populations ([@bib111]). However, it is also important to consider how these alternative methods (e.g., SVM) could add undue complication that make findings less interpretable for clinicians attempting to utilize these measures. An additional consideration for more traditional methodological approaches relates to the size of an ROI used in any given study and how that affects reliability. Researchers should consider the size of the functional activation they are attempting to capture and use appropriate ROIs that will accurately capture this. There is an obvious need within the field for more effort, energy, and resources to be spent on establishing reliable measures that provide clinically meaningful information. Importantly, this does not necessarily mean that researchers should start from scratch in terms of paradigm development. On the contrary, researchers can leverage data already collected as part of large, multi-site trials with data-sharing initiatives and can conduct rigorous test-retest reliability studies to identify the most stable measures associated with currently-used paradigms. The proposed "roadmap" is therefore often likely to be a winding road in which researchers circle-back to fill in methodological gaps.

7. Conclusion {#sec7}
=============

Stress-related neuroimaging tasks have perhaps the most potential for providing information about individual differences in neural processing that may be clinically useful for PTSD and other mental health disorders. However, this potential clinical utility is limited by gaps in methodological development. This review paper highlights research that has been conducted with stress-related human neuroimaging paradigms to establish basic reliability and validity. The emotional faces paradigm, which involves neural circuits of interest to stress-related mental health populations (i.e., amgydala), has received the most attention in this regard. Studies suggest that using specific contrasts and regions of interest with this task may increase test-retest and multi-site reliability. Other tasks, such as symptom provocation and fear learning tasks, have not been well scrutinized in terms of the reliability of neural response patterns. We outline a roadmap towards optimizing the potential clinical utility of neuroimaging tasks, which involves consideration of face/content and construct validity, test-retest and multi-site reliability, development of normative datasets, and concurrent and predictive validity ([Fig. 2](#fig2){ref-type="fig"}). By addressing these methodological gaps, we will likely have a powerful effect on improving the replicability of findings and optimize our chances for improving real-world clinical outcomes.
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[^1]: Unless otherwise noted, ICCs were absolute. \*Indicates relative ICC. ICCs \>0.4 are in bold. Interpretation of ICC values: poor (\<0.40), fair (0.41-0.59), good (0.60-0.74), excellent (\>0.75). Negative ICCs are interpreted as having zero reliability. Abbreviations: L = left; R = right; FmL = first block minus last block; ROI = region-of-interest; FFA = fusiform face area; sgACC = subgenual anterior cingulate cortex. Test-retest intervals are reported as they were in their respective studies. Unless otherwise noted, test-retest involved 2 scans.
